Polymyalgia Rheumatica Treatment Market Outlook
According to the report by Expert Market Research (EMR), the global polymyalgia rheumatica treatment market size is projected to grow at a CAGR of 4.7% between 2024 and 2032. Aided by the increasing focus on personalised medicine, the market is expected to grow significantly by 2032.
Polymyalgia rheumatica is an inflammatory disorder typically affecting adults over the age of 50. It is characterised by muscle pain and stiffness, particularly in the shoulders, neck, and hips. The precise cause of PMR is unknown, but it is believed to be related to autoimmune reactions and genetic factors.
The global polymyalgia rheumatica treatment market demand is primarily driven by the increasing prevalence of this condition, particularly among the aging population. The rise in the elderly population, who are more susceptible to such inflammatory diseases, is a key factor contributing to the market growth. Furthermore, advancements in medical research and diagnostics are enabling better identification and treatment of PMR, further fuelling market expansion.
Get a Free Sample Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market/requestsample
The primary treatment for polymyalgia rheumatica involves corticosteroids, which are effective in reducing inflammation and pain. The market for PMR treatment includes a range of corticosteroids, with prednisone being the most commonly prescribed medication. However, long-term use of corticosteroids is associated with potential side effects, leading to the demand for safer and more effective treatment options.
Biologic therapies are account for a significant portion of the polymyalgia rheumatica treatment market share. These therapies, which include tumour necrosis factor (TNF) inhibitors and interleukin-6 (IL-6) receptor blockers, offer targeted treatment and are often used in patients who do not respond adequately to corticosteroids. The development and approval of new biologic agents are expected to provide impetus to the market growth.
One of the key polymyalgia rheumatica treatment market trends is the growing focus on personalised medicine. Understanding the genetic and environmental factors contributing to PMR is leading to more tailored treatment approaches, improving patient outcomes and treatment efficacy.
Read Full Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market
The market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe are leading markets due to the high prevalence of PMR, well-established healthcare systems, and the presence of key pharmaceutical companies engaged in PMR research. The Asia Pacific region is also witnessing growth, driven by increasing awareness and improving healthcare infrastructure.
Polymyalgia Rheumatica Treatment Market Segmentation
The market can be divided based on diagnostic method, drug class, route of administration, end use, and region.
Market Breakup by Diagnostic Method
- Blood Tests
- Imaging Tests
Market Breakup by Drug Class
- Corticosteroids
- Disease-Modifying Anti-Rheumatic Drugs
- Nonsteroidal Anti-Inflammatory Drugs
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
Market Breakup by End Use
- Hospitals
- Homecare
- Speciality Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global polymyalgia rheumatica treatment market. Some of the major players explored in the report by Expert Market Research are as follows:
- Sanofi SA
- Apotex Corporation
- GlaxoSmithKline plc
- AbbVie Inc.
- Horizon Therapeutics plc
- Others
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact
Company Name: Claight Corporation
Contact Person: Christopher, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
